Chronic Obstructive Pulmonary Disease (COPD)
492
58
74
320
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
127 trials with published results (26%)
Research Maturity
320 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.9%
24 terminated out of 492 trials
93.0%
+6.5% vs benchmark
24%
118 trials in Phase 3/4
40%
127 of 320 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 320 completed trials
Clinical Trials (492)
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]
Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care
Screening for Pulmonary Embolism Using Single-channel Electrocardiogram
High Velocity Nasal Insufflation Versus Non Invasive Ventilation in COPD Patients With Acute Hypercapnic Respiratory Failure
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
The Impact of Training on Self-Efficacy, Symptom Level, and Activities of Daily Living
Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA
Effect of Inspiratory Muscle Training on Diaphragm Function in COPD Patients
Low Fat-free Mass in Prognosis of People With Chronic Obstructive Pulmonary Disease
Study of Patient With Frequent Exacerbations in Moscow
Study of Patient With Frequent COPD Exacerbations
Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness
Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Postural Control in Chronic Obstructive Pulmonary Disease
Force Control in Chronic Obstructive Pulmonary Disease